|
|
|
|
| LEADER |
01814nam a2200217 u 4500 |
| 001 |
EB002001534 |
| 003 |
EBX01000000000000001164435 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 020 |
|
|
|a 9789240001381
|
| 245 |
0 |
0 |
|a Guidelines for the management of pregnant and breastfeeding women in the context of Ebola virus disease
|h Elektronische Ressource
|
| 260 |
|
|
|a Geneva
|b World Health Organization
|c 2020, February 2020
|
| 300 |
|
|
|a 1 PDF file (43 pages)
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 710 |
2 |
|
|a World Health Organization
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK554101
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The Democratic Republic of Congo is currently experiencing the second largest Ebola outbreak in history, following a 2014-2016 outbreak in western Africa that had an estimated 28,000 cases. Investigational treatment and vaccination trials are ongoing, but data in the context of pregnancy and breastfeeding are limited. A paucity of scientific evidence exists on how to best treat pregnant or breastfeeding women with suspected or confirmed Ebola virus disease (EVD). Historical reports suggest that, among women who acquire EVD during pregnancy, there is increased mortality and morbidity, and a near 100% rate of adverse pregnancy outcomes. To save the lives of mothers and their babies, mitigate complications, and limit the spread of disease, it is critical that recommendations are made on the prevention, treatment, and surveillance of women who are exposed to EVD, acquire EVD during pregnancy or breastfeeding, or survive EVD with ongoing pregnancies. These guidelines are the first to provide such recommendations
|